期刊文献+

对1例癫痫合并肺部感染患者的药学监护

下载PDF
导出
摘要 目的探讨临床药师开展药学监护的方法。方法临床药师通过参与1例癫痫合并肺部感染患者的治疗过程,以药物的选择、药物相互作用及药物不良反应为切入点,探讨药学服务的内容。结果临床药师可结合患者的个体情况,在癫痫患者的肺部感染治疗过程中提出合理建议,并开展药学监护。结论药学服务形式多样,临床药师应结合自身专业优势,在合理用药中发挥作用。
出处 《中国实用医药》 2015年第13期215-216,共2页 China Practical Medicine
  • 相关文献

参考文献14

  • 1陈佰义,何礼贤,胡必杰,倪语星,邱海波,石岩,施毅,王辉,王明贵,杨毅,张菁,俞云松.中国鲍曼不动杆菌感染诊治与防控专家共识[J].中国医药科学,2012,2(8):3-8. 被引量:516
  • 2Kamfi W, Yell ET, Ross R, et al. Direct proinflammatory effect of creactive protein on human deothelial ceils. Infection, 1997 (329):115.
  • 3习慧明,徐英春,朱德妹,汪复,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳,俞云松,杨青.2010年中国CHINET鲍曼不动杆菌耐药性监测[J].中国感染与化疗杂志,2012,12(2):98-104. 被引量:212
  • 4Luna CM, Aruj PK. Nosocomial Acinetobacter, pneumonia. Respirology, 2007(12):787-791.
  • 5李冬梅,闫赋琴,孙慧萍.碳青霉烯类抗菌药物与丙戊酸存在临床意义的药物相互作用[J].中华医院感染学杂志,2011,21(19):4133-4134. 被引量:23
  • 6Powell-Jackson PR, Tredger JM, Williams R. Hepototoxicity to sodium valproate: a review. Gut, 1984(25):673-681.
  • 7Wyllie E, Wyllie R. Routine laboratory monitoring for serious adverse effect of antiepileptic medication: the controversy. Epilepsia, 1991, 32(5):S74.
  • 8Siemes H, Nau H, Schultze K, et al. Valproate(VPA) metabolites in various clinical conditions of probable VPA-associated hepatotoxicity. Epilepsia, 1993, 34(2):332.
  • 9Franklin IM, Elias E, Hirsch C. Fluconazole-induced jaundice. Lancet, 1990(336):565.
  • 10Bronstein JA, Gros P, Hernandez E, et al. Fatal acute hepatic necrosis due to dose-dependent fluconazole hepatotoxicity. Clin Infet Dis, 1997(25):1266-1267.

二级参考文献55

  • 1张小江,徐英春,俞云松,杨青,汪复,朱德妹,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳.2009年中国CHINET鲍曼不动杆菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):441-446. 被引量:137
  • 2Gu J, Huang Y. Effect of concomitant administration of meropenem and valproie acid in an elderly Chinese patient[J].Am J Geriatr Pharmacother, 2009,7 (1) : 26-33.
  • 3Haroutiunian S, Ratz Y, Rahinovich B, et al. Valproic acid plasma concentration decreases in a dose-independent manner following administration of meropenem: a retrospective study[J]. J Clin Pharmacol,2009,49(11): 1363-1369.
  • 4Suzuki E,Yamamura N,Ogura Y,etal. Identification of valproic acid glucuronide hydrolase as a key enzyme for the interaction of valproic acid with carbapenem antibiotics[J]. Drug Metab Dispos, 2010,38 (9) : 1538-1544.
  • 5Omoda K, Murakami T, Yumoto R, et al. Increased erythrocyte distribution of valproic acid in pharmacokinetic interaction with carbapenem antibiotics in rat and human [J]. J Pharm Sci, 2005,94(8) : 1685-1693.
  • 6Ogawa K, Yumoto R, Hamada N, et al. Interaction of valproic acid and carbapenem antibiotics with multidrug resistance-associated proteins in rat erythrocyte membranes[J]. Epilepsy Res,2006,71(1):76-87.
  • 7Clinical and Laboratory Standards Institute. Performancestandards for antimicrobial susceptibility testing~ twentieth information- al supplement[S]. CLSI, 2010,30 ( 1 ) : M100-S20.
  • 8Peleg AY, Seifert H, Paterson DL. Acinetobacterbauman- nil: emergence of a successful pathogen[J]. Clin Microbiol Rev,2008,21(3) :538-582.
  • 9Choi WS, Kim SH, Jeon EG, et al. Nosoeomial outbreak of carbapenem-resistant Acinetobacter baumannii in Intensive Care Units and successful outbreak control program[J]. J Korean Med Sci,2010, 25(7) :999-1004.
  • 10NNIS System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992through June 2003, issued August 2003 [J]. Am J Infect Control, 2003,31 (8) : 481 498.

共引文献725

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部